FimH Antagonists for the Oral Treatment of Urinary Tract Infections: From Design and Synthesis to in Vitro and in Vivo Evaluation

Tobias Klein; Daniela Abgottspon; Matthias Wittwer; Said Rabbani; Janno Herold; Xiaohua Jiang; Simon Kleeb; Christine Lüthi; Meike Scharenberg; Jacqueline Bezençon; Erich Gubler; Lijuan Pang; Martin Smiesko; Brian Cutting; Oliver Schwardt; Beat Ernst

doi:10.1021/jm101011y

journal article Open Access Nov 24, 2010

FimH Antagonists for the Oral Treatment of Urinary Tract Infections: From Design and Synthesis to in Vitro and in Vivo Evaluation

Tobias Klein

Daniela Abgottspon Matthias Wittwer Said Rabbani Janno Herold Xiaohua Jiang

Simon Kleeb Christine Lüthi Meike Scharenberg Jacqueline Bezençon Erich Gubler Lijuan Pang Martin Smiesko Brian Cutting Oliver Schwardt Beat Ernst

Journal of Medicinal Chemistry Vol. 53 No. 24 pp. 8627-8641 · American Chemical Society (ACS)

View at Publisher Save 10.1021/jm101011y

Topics

No keywords indexed for this article. Browse by subject →

References

74

[1]

Fihn S. D. N. Engl. J. Med. (2003) 10.1056/nejmcp030027

[2]

Recurrent urinary tract infection in women

Thomas M Hooton

International Journal of Antimicrobial Agents 2001 10.1016/s0924-8579(00)00350-2

[3]

Wiles T. J. Exp. Mol. Pathol. (2008) 10.1016/j.yexmp.2008.03.007

[4]

Gouin S. G. ChemMedChem (2009) 10.1002/cmdc.200900034

[5]

Rosen D. A. Infect. Immun. (2008) 10.1128/iai.00255-08

[6]

Mulvey M. A. Cell Microbiol. (2002) 10.1046/j.1462-5822.2002.00193.x

[7]

Capitani G. Microbes Infect. (2006) 10.1016/j.micinf.2006.03.013

[8]

X-ray Structure of the FimC-FimH Chaperone-Adhesin Complex from Uropathogenic Escherichia coli

Devapriya Choudhury, Andrew Thompson, Vivian Stojanoff et al.

Science 1999 10.1126/science.285.5430.1061

[9]

Receptor binding studies disclose a novel class of high‐affinity inhibitors of the Escherichia coli FimH adhesin

Julie Bouckaert, Jenny Berglund, Mark Schembri et al.

Molecular Microbiology 2005 10.1111/j.1365-2958.2004.04415.x

[10]

Wellens A. PLoS ONE (2008) 10.1371/annotation/ea59d179-0a71-4836-86f0-8d375f5df089

[11]

Vaccination with FimH Adhesin Protects Cynomolgus Monkeys from Colonization and Infection by UropathogenicEscherichia coli

Solomon Langermann, Roland Möllby, Jeanne E. Burlein et al.

The Journal of Infectious Diseases 2000 10.1086/315258

[12]

Prevention of Mucosal Escherichia coli Infection by FimH-Adhesin-Based Systemic Vaccination

Solomon Langermann, Susan Palaszynski, Michelle Barnhart et al.

Science 1997 10.1126/science.276.5312.607

[13]

Bouckaert J. Mol. Microbiol. (2006) 10.1111/j.1365-2958.2006.05352.x

[14]

Sharon N. Biochim. Biophys. Acta (2006) 10.1016/j.bbagen.2005.12.008

[15]

Firon N. Biochem. Biophys. Res. Commun. (1982) 10.1016/0006-291x(82)90947-0

[16]

Firon N. Carbohydr. Res. (1983) 10.1016/0008-6215(83)88019-7

[17]

Sharon N. FEBS Lett. (1987) 10.1016/0014-5793(87)80654-3

[18]

Neeser J.-R. Infect. Immun. (1986) 10.1128/iai.52.2.428-436.1986

[19]

Lindhorst T. K. Top. Curr. Chem. (2002) 10.1007/3-540-45010-6_7

[20]

Patel A. Carbohydr. Res. (2006) 10.1016/j.carres.2006.01.024

[21]

Nagahori N. ChemBioChem (2002) 10.1002/1439-7633(20020902)3:9<836::aid-cbic836>3.0.co;2-2

[22]

Appeldoorn C. C. M. Tetrahedron Asymmetry (2005) 10.1016/j.tetasy.2004.11.014

[23]

Touaibia M. ChemMedChem (2007) 10.1002/cmdc.200700063

[24]

Firon N. Infect. Immun. (1987) 10.1128/iai.55.2.472-476.1987

[25]

Lindhorst T. K. Eur. J. Org. Chem. (1998) 10.1002/(sici)1099-0690(199808)1998:8<1669::aid-ejoc1669>3.0.co;2-q

[26]

Sperling O. Org. Biomol. Chem. (2006) 10.1039/b610745a

[27]

Han Z. J. Med. Chem. (2010) 10.1021/jm100438s

[28]

eBerglund, J.; Bouckaert, J.; De Greve, H.; Knight, S.Anti-adhesive compounds to prevent and treat bacterial infections. International Patent Application PCT/US 2005/089733, 2005.

[29]

Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection

Chia‐Suei Hung, Julie Bouckaert, Danielle Hung et al.

Molecular Microbiology 2002 10.1046/j.1365-2958.2002.02915.x

[30]

Ernst B. Nature Rev. Drug Discovery (2009) 10.1038/nrd2852

[31]

Lindhorst T. K. Glycoconjugate J. (1998) 10.1023/a:1006920027641

[32]

Dubber M. Org. Biomol. Chem. (2006) 10.1039/b610741a

[33]

Touaibia M. ChemMedChem (2007) 10.1002/cmdc.200700063

[34]

Aronson M. J. Infect. Dis. (1979) 10.1093/infdis/139.3.329

[35]

Svanborg Eden C. Nature (1982) 10.1038/298560a0

[36]

Rabbani S. Anal. Biochem. (2010) 10.1016/j.ab.2010.08.007

[37]

Ness R. K. J. Am. Chem. Soc. (1950) 10.1021/ja01161a091

[38]

Sancho-Garcia J. C. J. Chem. Theory Comput. (2005) 10.1021/ct0500242

[39]

Eaton V. J. J. Chem. Soc., Faraday Trans. 2 (1973) 10.1039/f29736901601

[40]

Albert A. Nature (1958) 10.1038/182421a0

[41]

Winiwarter S. J. Med. Chem. (1998) 10.1021/jm9810102

[42]

Taketani M. Life Sci. (2007) 10.1016/j.lfs.2007.07.026

[43]

Kansy M. J. Med. Chem. (1998) 10.1021/jm970530e

[44]

Artursson P. Biochem. Biophys. Res. Com. (1991) 10.1016/0006-291x(91)91647-u

[45]

Varma M. V. S. J. Med. Chem. (2009) 10.1021/jm900403j

[46]

Abgottspon D. J. Microbiol. Methods (2010) 10.1016/j.mimet.2010.06.015

[47]

Uroplakin Ia is the urothelial receptor for uropathogenicEscherichia coli: evidence from in vitro FimH binding

Ge Zhou, Wen-Jun Mo, Peter Sebbel et al.

Journal of Cell Science 2001 10.1242/jcs.114.22.4095

[48]

Kartha K. P. R Tetrahedron (1997) 10.1016/s0040-4020(97)00742-4

[49]

Chittaboina S. Lett. Org. Chem. (2006) 10.2174/157017806774964521

[50]

Mori M. Carbohydr. Res. (1990) 10.1016/0008-6215(90)84167-s

Showing 50 of 74 references

Cited By

184

Bicyclic δ-Thiolactone Glycomimetics: Stereoselective Synthesis and Discovery of Stereocontrolled Antiphage Activity

Karol Postrożny, Bartosz Kamiński · 2026

The Journal of Organic Chemistry

Current and emerging strategies to curb antibiotic-resistant urinary tract infections

Aaron Simoni, Laura Schwartz · 2024

Nature Reviews Urology

Glycomimetics for the inhibition and modulation of lectins

Steffen Leusmann, Petra Ménová · 2023

Chemical Society Reviews

Antibiotic resistance and persistence—Implications for human health and treatment perspectives

Markus Huemer, Srikanth Mairpady Shambat · 2020

EMBO reports

FimH Antagonists: Bioisosteres To Improve the in Vitro and in Vivo PK/PD Profile

Simon Kleeb, Lijuan Pang · 2015

Journal of Medicinal Chemistry

Complementary and Integrative Therapies for Lower Urinary Tract Diseases

Donna M. Raditic · 2015

Veterinary Clinics of North America...

Study of the Structural and Dynamic Effects in the FimH Adhesin upon α-d-Heptyl Mannose Binding

Sophie Vanwetswinkel, Alexander N. Volkov · 2014

Journal of Medicinal Chemistry

Discovery and Application of FimH Antagonists

Sébastien G. Gouin, Goedele Roos · 2014

Topics in Medicinal Chemistry

Suppression of type 1 pilus assembly in uropathogenic Escherichia coli by chemical inhibition of subunit polymerization

Alvin W. H. Lo, Karen Van de Water · 2013

Journal of Antimicrobial Chemothera...

Thiazolylaminomannosides As Potent Antiadhesives of Type 1 Piliated Escherichia coli Isolated from Crohn’s Disease Patients

Sami Brument, Adeline Sivignon · 2013

Journal of Medicinal Chemistry

Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists

Oliver Schwardt, Said Rabbani · 2011

Bioorganic & Medicinal Chemistr...

Metrics

184

Citations

74

References

Details

Published: Nov 24, 2010
Vol/Issue: 53(24)
Pages: 8627-8641

Authors

T

Tobias Klein